FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079701 [Registered on: 29/01/2025] Trial Registered Prospectively
Last Modified On: 28/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A Study on the Efficacy of Sharbat Unnab and Herbal Formulations in Managing Atopic Dermatitis 
Scientific Title of Study   Efficacy of Sharbat Unnab with Lazuq of Kafoor, Rasot, Luaab Aspgol, Luaab Bartang in Atopic Dermatitis – A Randomized Single-Blind Placebo-Controlled Clinical Trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR NIKHAT ARA 
Designation  PG Scholar 
Affiliation  National Institute Of Unani Medicine  
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka 560091 India

Bangalore
KARNATAKA
560091
India 
Phone  9661399416  
Fax    
Email  nikhataratajpur@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Mohd Aleemuddin Quamari 
Designation  HOD Amraze Jild Wa Tazeeniyat & Moalajat (I/C) 
Affiliation  National Institute Of Unani Medicine 
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka 560091 India

Bangalore
KARNATAKA
560091
India 
Phone  9341072974  
Fax    
Email  drmaquamri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Mohd Aleemuddin Quamari 
Designation  HOD Amraze Jild Wa Tazeeniyat & Moalajat (I/C) 
Affiliation  National Institute Of Unani Medicine 
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka 560091 India

Bangalore
KARNATAKA
560091
India 
Phone  9341072974  
Fax    
Email  drmaquamri@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Unani Medicine Kottigepalya, Magadi Main Road Banglore 560091 Karnataka India 
 
Primary Sponsor  
Name  National Institute Of Unani Medicine 
Address  Department Of Amraze Jild Wa Tazeeniyat National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka 560091 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikhat Ara  National Institute Of Unani Medicine   Department Of Amraze Jild Wa Tazeeniyat OPD/IPD National Institute of Unani Medicine Kottigepalya Magadi Main Road Bangalore Karnataka 560091 India
Bangalore
KARNATAKA 
09341072974

drmaquamri@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Communication of Decision of the Institutional Ethics Committee (IEC) For Biomedical Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L209||Atopic dermatitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Placebo (caramel syrup orally and local application of liquid paraffin)  Oral administration of Carmel syrup is given: •5ml (5 yrs) •10ml (5-10yrs) •15ml (10 yrs) twice a day after meal. Apply petroleum jelly / liquid paraffin locally on affected area daily twice a day.  
Intervention  Sharbat unnab + Lazuq/Lasuq of kafoor, rasot, Luaab aspgol, Luaab bartang  Equal amount of kafoor and rasot (1:1) mixed together in the Luaab aspgol and Luaab bartang and stirred properly then soak a piece of cloth or cotton gauge in the same and apply the cotton cloth or cotton gauge locally on affected area, until the soaked cloth or cotton gauge gets dried. This should be applied twice daily. 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  1.Subjects with age between 2-18 years.
2.All gender.
3.Diagnosed cases of Atopic dermatitis as per Hannifin and Rajika Criteria.
 
 
ExclusionCriteria 
Details  1.Subjects who had previously applied topical treatments like corticosteroid or calcineurin inhibitors before 1 month of study.
2.Subjects who took following medication like systemic corticosteroids, and immunosuppressants, prior to 1 month of study.
3.Subjects who have types of dermatitis other than Atopic dermatitis-like stasis dermatitis, seborrheic dermatitis, contact dermatitis, nummular dermatitis.
4.Subjects who have Type 1 DM.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pharmacy-controlled Randomization 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Decrease in SCORAD index  Follow up: 0TH Day and 30th Day 
 
Secondary Outcome  
Outcome  TimePoints 
1.Decrease in Photography
2.POEM Questionnaire
 
1.Decrease in Photography
Follow up 0th Day,7th Day,14th Day,21th Day,28th Day
2.POEM Questionnaire
Follow up 0th Day,30th DAY

 
 
Target Sample Size   Total Sample Size="28"
Sample Size from India="28" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   17/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Purpose: To evaluate the efficacy of Sharbat unnab with Lazuq or Lasuq of kafoor, rasot, Luaab aspgol, Luaab bartang in comparison with placebo.
Design: A Randomized Single Blind Placebo Controlled Clinical Trial.
Intervention:        Test Group:  Sharbat unnab with  Lazuqor Lasuq of kafoor, rasot, Luaab aspgol, Luaab bartang, 
                           Control Group:  Placebo (caramel syrup orally and local application of liquid paraffin).
Main outcome measures:
Primary endpoint 
  1. Decrease in SCORAD index

 Secondary endpoint

1.     Decrease in Photography

2.     POEM Questionnaire

 
Close